Striatal dopaminergic abnormalities in human cocaine users

American Journal of Psychiatry

Volumn 156, Issue 2, 1999, Pages 238-245

  Little, Karley Y ^a   Zhang, Lian ^b   Desmond, Timothy ^b   Frey, Kirk A ^b   Dalack, Gregory W ^b   Cassin, Bader J ^b  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIHYDROTETRABENAZINE; DOPAMINE; DOPAMINE TRANSPORTER;

ADULT; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING SITE; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DOPAMINERGIC NERVE CELL; FEMALE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SUICIDAL BEHAVIOR;

ADOLESCENT; ADULT; AUTORADIOGRAPHY; CARRIER PROTEINS; COCAINE; COCAINE-RELATED DISORDERS; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; RECEPTORS, DOPAMINE; SEVERITY OF ILLNESS INDEX; TRITIUM;

EID: 0033023347     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. 3H]WIN 35428 binding sites in human striatum. Brain Res 1993; 628:17-25
2. Staley JK, Hearn L, Ruttenber J, Wetli CV, Mash DC: High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J Pharmacol Exp Ther 1994; 271:1678-1685
3. Little KY, McLaughlin DP, Zhang L, McFinton PR, Dalack GW, Cook EH Jr, Cassin BJ, Watson SJ: Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem study. Arch Gen Psychiatry 1998; 55:793-799
4. Hurd Y, Herkenham M: Molecular alterations in the neostriatum of human cocaine addicts. Synapse 1993; 13:357-369
5. Wilson JM, Levey AI, Bergeron C, Kalasinsky K, Ang L, Peretti F, Adams VI, Smialek J, Anderson WR, Shannak K, Deck J, Niznik HB, Kish SJ: Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Ann Neurol 1996; 40:428-439
6. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ: Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987; 237:1219-1223
7. [3H]GBR 12,935 are differentially regulated by chronic cocaine self-administration. J Neurosci 1994; 14:1121-1130
8. Hitri A, Little KY, Ellinwood EH: Effect of cocaine on dopamine transporter receptors depends on routes of chronic cocaine administration. Neuropsychopharmacology 1996; 14:205-210
9. Koff JM, Shuster L, Miller LG: Chronic cocaine administration is associated with behavioral sensitization and time-dependent changes in striatal dopamine transporter binding. J Pharmacol Exp Ther 1994; 268:277-282
10. Alburges ME, Narang N, Wamsley JK: Changes in the dopaminergic receptor system after chronic administration of cocaine. Synapse 1993; 14:314-323
11. Kula NS, Baldessarini RJ: Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine. Neuropharmacology 1991; 30:89-92
12. Benmansour S, Tejani-Butt SM, Hauptmann M, Brunswick DJ: Lack of effect of high-dose cocaine on monoamine uptake sites in rat brain measured by quantitative autoradiography. Psychopharmacology (Berl) 1992; 106:459-462
13. Vander Borght T, Kilbourn M, Desmond T, Kuhl D, Frey K: The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. Eur J Pharmacol 1995; 194:577-583
14. Little KY: Detecting acute drug effects. Biol Psychiatry 1989; 25:645-647
15. Little KY, Zhong H, Zhang L: Sodium effects on human dopamine transporter inhibitor binding site regulation. Abstracts of the Society for Neuroscience 1997; 23:1942
16. 3H]2β-carbomethoxy-3β-(4-fluorophenyl) tropane. Mol Pharmacol 1989; 36:518-524
17. [3H]WIN 35,428 binding to the dopamine uptake carrier, II: effect of membrane fractionation procedure and freezing. J Neurosci Methods 1994; 51:31-38
18. Mash DC, Ouyang Q, Pablo J, Eshelman AJ, Janowsky A: Functional studies of the dopamine transporter in post mortem human brain. Abstracts of the Society for Neuroscience 1997; 23:1102
19. Hitri A, Casanova MF, Kleinman JE, Wyatt RJ: Fewer dopamine transporter receptors in the prefrontal cortex of cocaine users. Am J Psychiatry 1994; 151:1074-1076
20. Little KY, Carroll FI, Butts JD: Striatal [125I]RTI-55 binding sites in cocaine-abusing humans. Prog Neuropsychopharmacol Biol Psychiatry 1998; 22:455-466
21. Yeh SY, DeSouza EB: Lack of neurochemical evidence for neurotoxic effects of repeated cocaine administration in rats on brain monoamine neurons. Drug Alcohol Depend 1991; 27:41-61
22. Ryan LJ, Martone ME, Linder JC, Groves PM: Cocaine, in contrast to d-amphetamine, does not cause axonal terminal degeneration in neostriatum and agranular frontal cortex of Long-Evans rats. Life Sci 1988; 43:1403-1409
23. Wilson M, Kish SJ: The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat. J Neurosci 1996; 16: 3507-3510
24. Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Gatley SJ, MacGregor RR, Wolf AP: Cocaine uptake is decreased in the brain of detoxified cocaine abusers. Neuropsychopharmacology 1996; 14:159-168
25. Sklair-Tavron L, Shi WX, Lane SB, Harris HW, Bunney BS, Nestler EJ: Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci USA 1996; 93:11202-11207
26. Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR, DelProposto ZS, Hill E, Cassin BJ, Watson SJ, Cook EH: Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 1998; 155:207-213